Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation

Neuroscience and Behavioral Physiology

Volumn 37, Issue 2, 2007, Pages 147-151

  Devoino, L V ^a   Al'perina, E L ^a   Gevorgyan, M M ^a   Cheido, M A ^a  

^a SCIENTIFIC RESEARCH INSTITUTE OF PHYSIOLOGY AND BASIC MEDICINE   (Russian Federation)

Author keywords

Dopamine D1 and D2 receptors; Immunomodulation; Mesolimbic dopaminergic system; Nucleus accumbens; Quinpirol; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; QUINPIROLE; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RAT STRAIN; SHEEP ERYTHROCYTE; ANALYSIS OF VARIANCE; ANIMAL; ERYTHROCYTE; IMMUNIZATION; IMMUNOLOGY; INJURY; METHODOLOGY; PHYSIOLOGY; ROSETTE FORMATION; SHEEP; WISTAR RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE AGONISTS; ERYTHROCYTES; IMMUNIZATION; MALE; NUCLEUS ACCUMBENS; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; ROSETTE FORMATION; SHEEP;

EID: 33845889779     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-007-0162-9     Document Type: Article

References (25)

1. E. L. Al'perina, "Involvement of dopaminergic brain structures in neuroimmunomodulation," Byul Sib. Otdel. Rus. Akad. Med. Nauk, 4, 40-45 (1994).
2. T. P. Vetlugina, The Immune System in Schizophrenia [in Russian], RASKO, Tomsk (2000).
3. L. V. Devoino and R. Yu. Il'yuchenok, Monoaminergic Systems in the Regulation of Immune Responses (Serotonin, Dopamine) [in Russian], Nauka, Novosibirsk (1983).
4. L. V. Devoino and R. Yu. Il'yuchenok, Neurotransmitter Systems in Psychoneuroimmunology: Dopamine, Serotonin, GABA, Neuropeptides [in Russian], TsÉRIS, Novosibirsk (1993).
5. L. V. Devoino, E. L. Al'perina, M. A. Cheido, and M. M. Gevorgyan, "Changes in the immune response in animals in conditions of activation and blockade of D 1 dopamine receptors," Zh. Éksperim. Klin. Farmakol., 90, No. 3, 120-125 (2004).
6. 2 dopamine receptors of the dorsolateral zone of the caudate nucleus to immunomodulation in rats," Ros. Fiziol. Zh. im. I. M. Sechenova, 90, No. 4, 1394-1400 (2004).
7. G. V. Idova, M. A. Cheido, and L. V. Devoino, "IgM and IgG rosette formation in the primary and secondary immune responses in the syngeneic spleen cell transfer system," Zh. Mikrobiol. Épidemiol. Immunobiologii, 2, 57-60 (1976).
8. G. N. Kryzhanovskii, S. V. Magaeva, V. Makarov, and R. I. Sepiashvili, Neuroimmunology [in Russian], Research Institute of General Pathology and Pathophysiology Press, Moscow (2003).
9. V. Ya. Semke, T. P. Vetlugina, T. I. Nevidimova, S. A. Ivanova, and N. A. Bokhan, Clinical Psychoneuroimmunology, RASKO, Tomsk (2003).
10. M. A. Cheido and E. L. Al'perina, "The immunostimulatory actions of the D-2 dopamine receptor agonist quinpirol," Byull. Éksperim. Biol. Med., 59, No. 4, 374-376 (1990).
11. 3 subtypes," Brain Res. Bull., 649, No. 1-2, 95-110 (1994).
12. M. Carlsson and A. Carlsson, "Schizophrenia: A subcortical neurotransmitter imbalance syndrome?" Schizophr. Bull., 16, 426-432 (1990).
13. A. J. Cunningham, "A method of increased sensitivity for detecting single antibody-forming cells," Nature, 207, 1106-1107 (1965).
14. L. Devoino, G. Idova, E. Alperina, and M. Cheido, "Brain neuromediator systems in the immune response control: Pharmacological analysis of pre-and postsynaptic mechanisms," Brain Res., 633, 267-274 (1994).
15. L. V. Devoino, E. L. Alperina, O. V. Galkina, and R. Yu. Ilyutchenok, "Involvement of brain dopaminergic structures in neuroimmunomodulation," Internat. J. Neurosci., 91, No. 3-4, 213-228 (1997).
16. R. G. Holden, I. S. Pakula, and P. A. Mooney, "A neuroimmunological model of schizophrenia and major depression: A review," J. Human Psychopharmacology, 12, 177-201 (1997).
17. J. F. R. Konig and R. A. Klippel, The Rat Brain. A Stereotaxic Atlas of the Forebrain and Low Parts of the Brain Stem, Williams and Wilkins Co Ltd, Baltimore (1963).
18. I. J. Kopin, "Neurotransmitters and disorders of the basal ganglia," in: Basic Neurochemistry: Molecular, Cellular and Medical Aspects, G. J. Seigel, et al. (eds.), Raven Press, New York (1994), pp. 899-918.
19. C. Missale, S. R. Nash, S. W. Robinson, M. Jaber, and M. G. Caron, "Dopamine receptors: From Structure to function," Physiol. Rev., 78, No. 1, 196-214 (1998).
20. N. Muller, M. Riedel, R. Gruber, M. Ackenheil, and M. J. Scharz, "The immune system and schizophrenia: An integrative view," Ann. N.Y. Acad. Sci., 917, 456-467 (2000).
21. 1 receptors in the limbic system in the control of immune mechanisms," Neuroimmunomodulation, 1, No. 3, 174-180 (1994).
22. G. P. Reynolds, "Developments of the drug treatment of schizophrenia," Trends Pharmacol. Sci., 13, 116-121 (1992).
23. 3) as a target for neuroleptics," Nature, 347, 146-151 (1990).
24. C. W. Tsao, Y. S. Lin, and J. T. Cheng, "Effect of dopamine on immune cell proliferation in mice," Life Sci., 61, No. 24, 361-371 (1997).
25. B. Weise, S. P. Zhang, and L. W. Zhou, "Antisense strategies in dopamine receptor pharmacology," Life Sci., 60, No. 7, 433-455 (1997).